Two patients (cases 16 and 27) were not in remission of their medulloblastoma and thus not eligible for bone marrow transplant, and one patient died in remission of his AML-MLL leukemia during bone marrow transplant. The gene discussed is KMT2A; the disease is acute myeloid leukemia.